Clene Provides Update on ALS Clinical Development Meeting With FDA
Go back to Clene Provides Update on ALS Clinical Development Meeting With FDA| (NASDAQ: CLNN) | Delayed: 3.73 -0.03 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.76 | 52 Week High | $ | |||
| Open | $3.73 | 52 Week Low | $ | |||
| Day High | $3.73 | P/E | N/A | |||
| Day Low | $3.73 | EPS | $ | |||
| Volume | 289 | |||||



